Paul Sean Little - 11 Jun 2021 Form 4 Insider Report for Eledon Pharmaceuticals, Inc. (ELDN)

Role: CHIEF FINANCIAL OFFICER
Signature: /s/ Ryan A. Murr, as attorney-in-fact for Paul Little
Issuer symbol: ELDN
Transactions as of: 11 Jun 2021
Net transactions value: +$88,700
Form type: 4
Filing time: 14 Jun 2021, 17:24:30 UTC
Next filing: 02 Feb 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ELDN	Common Stock	Purchase	$88,700	+10,000		$8.87^*	10,000	11 Jun 2021	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reported price in Column 4 is a weighted average price. These shares were purchased in multiple open market transactions in accordance with the Issuer's trading policies at prices ranging from $8.76 to $8.99 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Content

The reported price in Column 4 is a weighted average price. These shares were purchased in multiple open market transactions in accordance with the Issuer's trading policies at prices ranging from $8.76 to $8.99 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.